Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 6, 2001, Pages 2763-2768

  Oleksik, Anna M ^a   Duong, Tu ^b   Pliester, Nicolette ^a   Asma, Greetje ^a   Popp Snijders, Corrie ^a   Lips, Paul ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; GLUCOSE HOMEOSTASIS; GROWTH HORMONE RELEASE; GROWTH REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; INSULIN METABOLISM; INSULIN SENSITIVITY; LIVER CLEARANCE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034966336     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.6.7549     Document Type: Article

References (52)

1. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene
2. The Bedford survey ten-year mortality rates in newly diagnosed diabetics, borderline diabetics, and normoglycaemic controls, and risk indices for coronary heart disease in borderline diabetics
3. Insulin and atheroma: 20-Year perspective
4. Gender differences in insulin-like growth factor and bone mineral density: The Rancho Bernardo Study
5. Effects of estrogen deficiency on IGF-1 plasma levels: Relationship with bone mineral density in perimenopausal women
6. Insulin-like growth factors and osteoporosis
7. Effects of sex and age on 24-hour profile of growth hormone secretion in men: Importance of endogenous estradiol concentrations
8. Metabolic effects of human and monkey growth hormone in man
9. Growth hormone (replacement) therapy in adults: Bone and calcium metabolism
10. Growth hormone (GH) therapy in GH deficient adults: Effects on bone and mineral metabolism
11. Insulin-like growth factors and IGF-binding proteins: Their use for diagnostics of growth hormone deficiency
12. Regulation of hepatic expression of IGF I and fetal IGF binding protein mRNA in streptozoticin-diabetic rats
13. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man
14. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and improves insulin sensitivity in humans
15. Insulin-like growth factor I inhibits glucose stimulated insulin secretion but does not impair glucose metabolism in normal humans
16. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino-acids
17. A low-dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans
18. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women
19. Ageing and the response of plasma insulin, glucose and C-peptide concentration to intravenous glucose in postmenopausal women
20. The influence of female sex steroids on glucose metabolism and insulin action: Human studies
21. Impact of short-term estrogen administration on growth hormone secretion and activation: Distinct route-dependent effects on connective and bone tissue metabolism
22. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women
23. Transdermal 17β-estradiol combined with oral progesteron increases plasma levels of insulin-like growth factor I in postmenopausal women
24. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women
25. The effect of estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women
26. The insulin-like growth factor I generation test: Resistance to growth hormone with ageing and estrogen replacement therapy
27. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: Effects of physiological estrogen replacement
28. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women
29. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women
30. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women
31. Effects of postmenopausal hormone therapy on glucose and insulin concentrations
32. The effects of raloxifene on risk of breast cancer in postmenopausal women
33. Both oral and transdermal estrogen replacement increase GH release in postmenopausal women-a clinical research center study
34. Effects of tamoxifen on serum insulinelike growth factor levels in stage I breast cancer patients
35. Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-1 serum levels in women with breast cancer
36. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor axis in younger and older postmenopausal women: A clinical research center study
37. Sex steroid regulation of growth hormone secretion and action
38. Regulation of insulin-like growth factor I receptor expression by the pure anti-estrogen ICI 182780
39. Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation
40. Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy
41. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men
42. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans
43. Actions of estrogen on pulsatile, nyctohemeral, and entropic models of growth hormone secretion
44. Effects of progestin-opposed transdermal estrogen administration on GH and IGF-I in postmenopausal women of different ages
45. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatropism of obesity in man
46. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin
47. Effects of low dosis of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women
48. Induction of insulin resistance by androgens and estrogens
49. Factors associated with glucose and insulin in healthy postmenopausal women
50. How good a marker is insulin level for insulin resistance?
51. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp
52. The IGF-I response to very low rhGH doses is preserved in human ageing